Increased Caffeine Consumption Is Associated With Reduced Hepatic Fibrosis
Top Cited Papers
Open Access
- 23 December 2009
- journal article
- research article
- Published by Wolters Kluwer Health in Hepatology
- Vol. 51 (1) , 201-209
- https://doi.org/10.1002/hep.23279
Abstract
Although coffee consumption has been associated with reduced frequency of liver disease, it is unclear whether the effect is from coffee or caffeine and whether there is an effect on hepatic fibrosis specifically. This study was undertaken to use a food-frequency instrument for dietary caffeine consumption to evaluate the relationship between caffeine intake and liver fibrosis. Patients undergoing liver biopsy completed a detailed caffeine questionnaire on three occasions over a 6-month period. Caffeine intake was compared between patients with mild and advanced liver fibrosis (bridging fibrosis/cirrhosis). Logistic regression was used to evaluate the association between caffeine consumption and hepatic fibrosis. One hundred seventy-seven patients (99 male, 104 white, 121 with chronic hepatitis C virus [HCV] infection) undergoing liver biopsy completed the caffeine questionnaire on up to three occasions. Results from repeated questionnaires were consistent. Daily caffeine consumption above the 75th percentile for the cohort (308 mg = approximately 2.25 cups of coffee equivalents) was associated with reduced liver fibrosis (odds ratio [OR], 0.33; 95% confidence interval [CI], 0.14-0.80; P = 0.015) and the protective association persisted after controlling for age, sex, race, liver disease, body mass index, and alcohol intake in all patients (OR, 0.25; 95% CI, 0.09-0.67; P = 0.006), as well as the subset with HCV infection (OR, 0.19; 95% CI, 0.05-0.66; P = 0.009). Despite a modest trend, consumption of caffeine from sources other than coffee or of decaffeinated coffee was not associated with reduced liver fibrosis. A reliable tool for measurement of caffeine consumption demonstrated that caffeine consumption, particularly from regular coffee, above a threshold of approximately 2 coffee-cup equivalents per day, was associated with less severe hepatic fibrosis. (Hepatology 2010;51:201–209.)Keywords
This publication has 28 references indexed in Scilit:
- Induction of cancer chemopreventive enzymes by coffee is mediated by transcription factor Nrf2. Evidence that the coffee-specific diterpenes cafestol and kahweol confer protection against acroleinToxicology and Applied Pharmacology, 2008
- Coffee drinking and hepatocellular carcinoma riskHepatology, 2007
- Coffee Consumption and Risk of Liver Cancer: A Meta-AnalysisGastroenterology, 2007
- Coffee, Cirrhosis, and Transaminase EnzymesArchives of internal medicine (1960), 2006
- Coffee, Tea, and Caffeine Consumption and Incidence of Colon and Rectal CancerJNCI Journal of the National Cancer Institute, 2005
- Coffee and caffeine consumption reduce the risk of elevated serum alanine aminotransferase activity in the United StatesGastroenterology, 2005
- Coffee, Caffeine, and the Risk of Liver CirrhosisAnnals of Epidemiology, 2001
- Coffee consumption and serum aminotransferases in middle-aged Japanese menPublished by Elsevier ,2001
- Coffee consumption and decreased serum gamma-glutamyltransferase and aminotransferase activities among male alcohol drinkersInternational Journal of Epidemiology, 1998
- Histological grading and staging of chronic hepatitisJournal of Hepatology, 1995